D. Barbie

Oncology · 2000–2018

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom D. Barbie trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Pardoll

Who trusts D. Barbie overall

  1. D. Aran
  2. Sonja Hänzelmann
  3. Zachary A. Knight
  4. Yifeng Xia
  5. Michael S. Rooney

Papers from D. Barbie's perspective

Ordered by how strongly the researchers D. Barbie trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma (Cell)
  2. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
  3. Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells (Science Translational Medicine)
  4. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
  5. Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates (Journal of Clinical Oncology)
  6. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma (New England Journal of Medicine)
  7. Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity (Nature)
  8. Neoantigens in cancer immunotherapy (Science)
  9. The future of immune checkpoint therapy (Science)
  10. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade (Science)

Their papers